Delivery Order SPE2DB22D3009-SPE2DB25FAY76
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $6,798.81 under firm fixed pricing terms, with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lidocaine 5% Patch 30S, a topical pain management pharmaceutical product. This firm fixed-price delivery order, valued at $2,671.51, is scheduled for completion by August 11, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $2,548.77 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be delivered to the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $4,961.89. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed-price delivery order, valued at $1,534.00, is set to be completed by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-competitive award issued without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $2,761.61 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed and delivered from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,433.76 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication used for localized pain relief. The contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,551.14 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The contract, awarded on June 11, 2025, with an ultimate completion date of June 12, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, serving as the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,834.22 and firm fixed pricing. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lidocaine 5% Patch 30s, with a contract ceiling value of $11,708.53. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, executed without a set-aside designation, indicating competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FAY76Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,158.32 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements across multiple therapeutic domains through competitive awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 6/5/25 |